KCL-286

Names

[ CAS No. ]:
1952276-71-9

[ Name ]:
KCL-286

Biological Activity

[Description]:

Anticancer agent 168 is an orally active retinoic acid receptor (RAR/RXR) beta2 agonist with ameliorating effects on spinal cord injury (SCI)[1].

[Related Catalog]:

Research Areas >> Others

Signaling Pathways >> Metabolic Enzyme/Protease >> RAR/RXR

[Target]

RAR β2[1]

[References]

[1]. Goncalves MB, et al. Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participants. Br J Clin Pharmacol. 2023 Jul 15..

Chemical & Physical Properties

[ Molecular Formula ]:
C₁₉H₁₄N₂O₄

[ Molecular Weight ]:
334.33

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.